BCL-6 Overexpression as a Predictor for Endometriosis in Patients Undergoing In Vitro Fertilization
- PMID: 33414614
- PMCID: PMC7757768
- DOI: 10.4293/JSLS.2020.00064
BCL-6 Overexpression as a Predictor for Endometriosis in Patients Undergoing In Vitro Fertilization
Abstract
Objective: To evaluate the positive predictive value (PPV) of endometrial BCL-6 overexpression as a noninvasive screening test endometriosis in patients undergoing in vitro fertilization (IVF).
Methods: Retrospective cohort study at a university-affiliated private practice. Inclusion criteria were reproductive age females currently undergoing IVF with a diagnosis of unexplained infertility or unexplained recurrent pregnancy loss. Those with endometrial BCL-6 overexpression underwent laparoscopic surgery with an indication for treatment of suspected endometriosis. The primary outcome was the PPV of endometrial BCL-6 testing to surgically diagnose endometriosis. Statistical analysis was performed using SPSS v.25.0.
Results: Seventy-five patients met inclusion criteria for our study. The PPV of BCL-6 testing for endometriosis was 96%. Of those patients without endometriosis, 100% had other inflammatory pelvic pathologies, which were diagnosed and treated at the time of laparoscopy.
Conclusions: Endometrial BCL-6 overexpression has a high PPV for diagnosing endometriosis and can help identify a patient population that may require surgical treatment before embryo transfer.
Keywords: BCL6; Endometriosis; In Vitro Fertilization; Recurrent Pregnancy Loss; Unexplained Infertility.
© 2020 by JSLS, Journal of the Society of Laparoscopic & Robotic Surgeons.
Conflict of interest statement
Conflicts of Interest: The authors declare no conflict of interest.
Figures
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous